Functional tumor-derived exosomes in NSCLC progression and clinical implications
Frontiers in Pharmacology,
Год журнала:
2025,
Номер
16
Опубликована: Март 19, 2025
Non-small
cell
lung
cancer
(NSCLC)
accounts
for
approximately
85%
of
all
cases
and
remains
one
the
leading
causes
cancer-related
mortality
worldwide.
The
high
rate
is
primarily
driven
by
delayed
diagnosis,
rapid
metastasis,
frequent
recurrence.
Tumor-derived
exosomes
(TEXs)
have
emerged
as
critical
mediators
in
NSCLC
progression,
offering
valuable
insights
into
tumor
microenvironment.
Exosomes
are
small
membrane
vesicles
that
facilitate
intercellular
communication
transport
bioactive
molecules,
including
proteins,
RNAs,
DNAs,
thereby
reflecting
genetic
complexity
tumors.
These
play
a
key
role
promoting
epithelial-mesenchymal
transition
(EMT),
neovascularization,
drug
resistance,
immune
evasion,
which
pivotal
development
NSCLC.
This
review
explores
diverse
roles
TEXs
focusing
on
their
involvement
pre-metastatic
niche
formation,
tissue
modulation.
Specifically,
we
discuss
exosome-associated
RNAs
proteins
NSCLC,
contribute
to
growth
metastasis.
Furthermore,
explore
potential
biomarkers
emphasizing
application
prognosis,
prediction
resistance
targeted
therapies
immunotherapies.
Язык: Английский
The silent spread: exploring diverse metastatic pathways in high-grade serous ovarian cancer
Frontiers in Medicine,
Год журнала:
2025,
Номер
12
Опубликована: Март 5, 2025
High-grade
serous
ovarian
cancer
(HGSOC)
is
a
highly
aggressive
and
deadly
gynecological
cancer,
with
metastasis
being
key
factor
in
its
poor
prognosis.
Historically,
HGSOC
was
thought
to
spread
primarily
through
the
peritoneal
cavity,
but
recent
research
has
revealed
additional
routes
of
metastasis,
including
blood
lymphatic
systems.
This
review
discusses
complex
processes
focusing
on
immune
suppression,
stromal
reprogramming,
role
circulating
tumor
cells
blood-based
spread.
We
also
explore
clinical
significance
particularly
impact
patient
outcomes.
Gaining
insight
into
molecular
genetic
drivers,
such
as
BRCA
mutations
interactions
within
microenvironment,
essential
for
developing
targeted
treatments.
Future
studies
should
aim
enhance
experimental
models,
identify
early
detection
markers,
investigate
novel
therapeutic
approaches
effectively
address
improve
survival.
Язык: Английский